findmyKOL
Clinical trialNCT00501735CompletedPhase 2Interventional

Forodesine in the Treatment of Cutaneous T-Cell Lymphoma

SponsorBioCryst PharmaceuticalsEnrollment144Cutaneous T-cell Lymphoma (CTCL),
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a Phase II, non-randomized, open-label, single-arm trial that will be conducted at up to 50 sites in North America, Europe and Australia. This study is designed to assess objective response (OR) \[complete response (CR) or partial response (PR)\] in subjects with cutaneous manifestations of CTCL with a requirement for maintenance of such objective response for at least 28 days in subjects with stage IIB, III, and IVA CTCL. Additionally, this study will evaluate the safety and tolerability of CTCL subjects Stages IB, IIA, IIB, III, or IVA treated with oral forodesine.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

41 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Cabrini Hospital

    Malvern, Victoria, Australia

Austria
  • Wien

    Vienna, Austria

Finland
  • Helsinki

    Helsinki, Finland

France
  • Hopital Hotel-Dieu

    Clermont-Ferrand, France

  • Creteil

    Créteil, France

  • Montpellier

    Montpellier, France

  • Pessac

    Pessac, France

  • Chu Robert Debre

    Reims, France

  • Toulouse

    Toulouse, France

Germany
  • Campus Charité Mitte

    Berlin, Germany

  • Universitatsklinikum Jena

    Jena, Germany

  • Universitat Kiel

    Kiel, Germany

  • Klinik Fur Dermatologie, Venerologie Und Allergologie

    Mannheim, Germany

Italy
  • Bologna

    Bologna, Italy

  • Firenze

    Florence, Italy

  • Milan

    Milan, Italy

  • Rome

    Rome, Italy

  • Torino

    Torino, Italy

Spain
  • Madrid

    Madrid, Spain

Switzerland
  • Zurich

    Zurich, Switzerland

United Kingdom
  • London

    London, United Kingdom

  • Manchester

    Manchester, United Kingdom

United States
  • University of Alabama at Birmingham, Comprehensive Cancer Ctr

    Birmingham, Alabama, United States

  • Stanford University Medical Center

    Stanford, California, United States

  • Yale Cancer Center

    New Haven, Connecticut, United States

  • Moffitt Cancer Center

    Tampa, Florida, United States

  • Emory University

    Atlanta, Georgia, United States

  • Lsu Health Sciences Center, Feist-Weiller Cancer Center

    Shreveport, Louisiana, United States

  • Boston Medical Center

    Boston, Massachusetts, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • Hackensack University Medical Ctr

    Hackensack, New Jersey, United States

  • Upstate Medical University

    Syracuse, New York, United States

  • Duke University Medical Center

    Durham, North Carolina, United States

  • Wake Forest University Health Sceinces, Dept. of Dermatology

    Winston-Salem, North Carolina, United States

  • Gabrail Cancer Center

    Canton, Ohio, United States

  • University Hospitals Case Medical Center, Dept. of Dermatology

    Cleveland, Ohio, United States

  • Hospital at the University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • Hillman Cancer Ctr., University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • M.D. Anderson Cancer Center - Dermatology

    Houston, Texas, United States

  • Seattle Cancer Care Alliance

    Seattle, Washington, United States

1 more site on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Forodesine
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2007
Primary completion
31 Jul 2010
Completion
31 Dec 2011
Last update posted
23 Jan 2012
Registered enrollment
144
Registry id
NCT00501735
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.